Indies Pharma Jamaica Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 16 shareholders own 90.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
75.6%	Bioprist Holding Inc.	1,007,985,032	JA$3.1b	-0.03%	no data
4.25%	Gk Investments Limited	56,664,881	JA$174.0m	1.41%	30.59%
3.37%	Sunand Gogieni	44,903,438	JA$137.9m	0%	no data
1.74%	Vishnu Muppuri	23,171,070	JA$71.1m	0%	no data
1.5%	NCB Capital Markets Ltd.	20,000,000	JA$61.4m	0%	0.44%
1.34%	Barita Investments Limited, Asset Management Arm	17,894,568	JA$54.9m	0%	1.2%
1.33%	Victoria Mutual Wealth Management Limited, Asset Management Arm	17,781,914	JA$54.6m	0%	1.3%
0.61%	Sagicor Pooled Investment Funds Limited	8,172,077	JA$25.1m	0%	0.14%
0.57%	Lloyd Badal	7,536,989	JA$23.1m	1.17%	no data
0.45%	Barita Unit Trusts Management Company Ltd.	5,967,082	JA$18.3m	0%	0.94%
0.05%	Kevin Donaldson	660,801	JA$2.0m	0%	no data
0.015%	Trevor McCartney	200,000	JA$614.0k	0%	no data
0.015%	Lissant Mitchell	200,000	JA$614.0k	0%	no data
0.0076%	Ricardo Stephenson	101,000	JA$310.1k	0%	no data
0.0037%	Dwight Brown	50,000	JA$153.4k	0%	no data
0.0011%	Sabrina Serrant	15,000	JA$46.2k	0%	no data